相关实验视频

Updated: Jun 11, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

基于生物信息学的肝癌中MYL6B的表达和预后关系的研究

Hai-Bing Lv¹, Qing-Yun Wu², Yu-Jiao Zhang³

¹Department of General Surgery, Beidahuang Group General Hospital, Harbin 150000, Heilongjiang Province, China.

World journal of clinical oncology

|October 1, 2024

概括

肝肝细胞癌 (LIHC) 中MYL6B的高表达与预后不佳和免疫透增加相关. MYL6B为LIHC提供了潜在的治疗点,为治疗提供了新的途径.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

初级肝癌 (肝细胞癌) 预后不好,复发率高,需要早期检测策略.
包括MYL6B在内的髓蛋白与癌症进展有关,影响细胞迁移,入侵和瘤抑制.
MYL6B与其他癌症的不良结果有关,并显示出作为诊断生物标志物的潜力.

研究的目的:

为了研究MYL6B在肝肝细胞癌 (LIHC) 中的表达模式.
评估LIHC患者MYL6B表达的预后意义.
使用生物信息学方法探索LIHC中MYL6B作用的潜在机制.

主要方法:

利用生物信息数据库 (GIPIA2,TIMER) 来分析MYL6B在癌和LIHC组织中的表达.
在LIHC中,MYL6B表达水平与总生存率和无病生存率相关.
进行了免疫组织化学分析,以评估MYL6B蛋白水平及其与免疫细胞透和蛋白质-蛋白质相互作用网络的关联.

主要成果:

在LIHC和其他癌症中,MYL6B的调节显著上升,随着癌症的进展,表达增加.
在LIHC患者中,高MYL6B表达与较差的整体存活率和无复发存活率有很强的相关性.
在LIHC组织中观察到较高的MYL6B水平,并与增加的免疫透和炎症有关.

结论:

与正常肝脏组织相比,MYL6B在LIHC中显著过度表达.
在LIHC中,MYL6B表达水平与瘤分化,生存率和免疫透相关.
MYL6B代表了肝肝细胞癌的一个有前途的治疗点.

关键词:

生物信息学是一种生物信息学.表达方式表达方式表达肝癌是一种肝癌.这就是MYL6B.预后预后预测预测

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...